Detalles de la búsqueda
1.
In vivo pharmacodynamic characterization of a next-generation polyene, SF001, in the invasive pulmonary aspergillosis mouse model.
Antimicrob Agents Chemother;
68(3): e0163123, 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38319077
2.
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae.
Antimicrob Agents Chemother;
67(4): e0221321, 2023 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36946741
3.
Impact of antibiotic pharmacokinetics in urine on recurrent bacteriuria following treatment of complicated urinary tract infections.
Antimicrob Agents Chemother;
67(10): e0053523, 2023 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37768311
4.
Gepotidacin Pharmacokinetics-Pharmacodynamics against Escherichia coli in the One-Compartment and Hollow-Fiber In Vitro Infection Model Systems.
Antimicrob Agents Chemother;
65(12): e0012221, 2021 11 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34543096
5.
Pharmacokinetic-Pharmacodynamic Characterization of Omadacycline against Haemophilus influenzae Using a One-Compartment In Vitro Infection Model.
Antimicrob Agents Chemother;
64(6)2020 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32284378
6.
Population Pharmacokinetic Analyses for Omadacycline Using Phase 1 and 3 Data.
Antimicrob Agents Chemother;
64(7)2020 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32340986
7.
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Dose Selection for ME1100, an Arbekacin Inhalation Solution.
Antimicrob Agents Chemother;
64(10)2020 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32661000
8.
Relationship between Gepotidacin Exposure and Prevention of On-Therapy Resistance Amplification in a Neisseria gonorrhoeae Hollow-Fiber In Vitro Infection Model.
Antimicrob Agents Chemother;
64(10)2020 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32661002
9.
Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST).
Antimicrob Agents Chemother;
64(2)2020 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31767718
10.
Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an In Vitro Pharmacodynamic Model.
Antimicrob Agents Chemother;
64(4)2020 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32041712
11.
Methodological features of clinical pharmacokinetic-pharmacodynamic studies of antibacterials and antifungals: a systematic review.
J Antimicrob Chemother;
75(6): 1374-1389, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32083674
12.
APX001 Pharmacokinetic/Pharmacodynamic Target Determination against Aspergillus fumigatus in an In Vivo Model of Invasive Pulmonary Aspergillosis.
Antimicrob Agents Chemother;
63(4)2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30670426
13.
Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Aminomethylcycline Antibiotic, KBP-7072, in the Neutropenic Murine Pneumonia Model against Staphylococcus aureus and Streptococcus pneumoniae.
Antimicrob Agents Chemother;
63(3)2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30559140
14.
Population Pharmacokinetic Analyses for Arbekacin after Administration of ME1100 Inhalation Solution.
Antimicrob Agents Chemother;
63(8)2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31182524
15.
Pharmacokinetic/Pharmacodynamic Evaluation of Solithromycin against Streptococcus pneumoniae Using Data from a Neutropenic Murine Lung Infection Model.
Antimicrob Agents Chemother;
63(8)2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31182534
16.
Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections.
Antimicrob Agents Chemother;
63(8)2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31109982
17.
Apotransferrin in Combination with Ciprofloxacin Slows Bacterial Replication, Prevents Resistance Amplification, and Increases Antimicrobial Regimen Effect.
Antimicrob Agents Chemother;
63(5)2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30782989
18.
Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies.
Antimicrob Agents Chemother;
63(4)2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30670433
19.
Pharmacokinetic/pharmacodynamic target attainment analyses to support intravenous and oral lefamulin dose selection for the treatment of patients with community-acquired bacterial pneumonia.
J Antimicrob Chemother;
74(Suppl 3): iii35-iii41, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30949705
20.
Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis.
Clin Infect Dis;
67(suppl_3): S274-S283, 2018 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30496459